venlafaxine hydrochloride has been researched along with Morphine Dependence in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Alboghobeish, S; Amirgholami, N; Ghorbanzadeh, B; Houshmand, G; Mansouri, MT; Naghizadeh, B | 2 |
Alboghobeish, S; Amirgholami, N; Cauli, O; Ghorbanzadeh, B; Houshmand, G; Mansouri, MT; Naghizadeh, B | 1 |
Ge, X; Lu, L; Ma, L; Pei, G; Su, F; Su, WJ; Yue, W | 1 |
4 other study(ies) available for venlafaxine hydrochloride and Morphine Dependence
Article | Year |
---|---|
Venlafaxine inhibits naloxone-precipitated morphine withdrawal symptoms: Role of inflammatory cytokines and nitric oxide.
Topics: Animals; Cytokines; Male; Mice; Morphine; Morphine Dependence; Naloxone; Nitric Oxide; Serotonin and Noradrenaline Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2020 |
Venlafaxine Attenuates the Development of Morphine Tolerance and Dependence: Role of L-Arginine/Nitric Oxide/cGMP Pathway.
Topics: Analgesics, Opioid; Animals; Arginine; Behavior, Animal; Brain; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Male; Mice; Morphine; Morphine Dependence; Nitric Oxide; Nociceptive Pain; Signal Transduction; Time Factors; Venlafaxine Hydrochloride | 2018 |
Venlafaxine prevents morphine antinociceptive tolerance: The role of neuroinflammation and the l-arginine-nitric oxide pathway.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Brain; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutathione Peroxidase; Lipid Peroxidation; Male; Mice; Morphine; Morphine Dependence; NG-Nitroarginine Methyl Ester; Nitrites; Oxidative Stress; Pain Measurement; Signal Transduction; Venlafaxine Hydrochloride | 2018 |
Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor.
Topics: Adrenergic Uptake Inhibitors; Animals; Conditioning, Psychological; Cyclohexanols; Dopamine Antagonists; Exploratory Behavior; Male; Morphine Dependence; Motor Activity; Norepinephrine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Sulpiride; Venlafaxine Hydrochloride | 2001 |